Compositions and methods for treating lung disease and injury

摘要

Disclosed is a use of a combination of at least one nucleic acid TLR2 inhibitor or a pharmaceutically acceptable salt thereof, and at least one nucleic acid TLR4 inhibitor or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating a lung disorder, a lung disease or a lung injury.